Janus kinase inhibitor baricitinib is not an ideal option for management of COVID-19
| Autor: | Praveen, D., Puvvada, Ranadheer Chowdary, M, Vijey Aanandhi |
|---|---|
| Zdroj: | In International Journal of Antimicrobial Agents May 2020 55(5) |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect